搜尋結果
Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...
2021年3月9日 · Haematologists from the University of Hong Kong (HKU) have reported initial success with chimeric antigen receptor (CAR) T-cell therapy, treating the first patient in Hong Kong in May 2020 in a global lymphoma trial and another leukaemia patient in October 2020 in a real-world clinical practice setting.
Search company information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account ...
Although guideline-directed medical therapies (GDMTs) for heart failure (HF) with reduced ejection fraction (HFrEF) are effective in reducing risks of mortality and hospitalization for HF (HHF), the clinical burden of HF remains high. At a recent scientific symposium, Dr Yuya Matsue of Juntendo University Graduate School of Medicine in Japan ...
MIMS home. Drugs. Info. Shin-Biofermin S新表飛鳴. / Concise Prescribing Info. Contents. Conc Bifidobacterium bifidum 2 mg, conc Lactobacillus acidophilus powd 2 mg, conc S. faecalis powd 2 mg. Indications/Uses. Intestinal regulation (regulate one's stool), loose stool, constipation, meteorism.
MIMS home. Drugs. Info. Herbesser 30/Herbesser 60合心爽. diltiazem. Concise Prescribing Info. Contents. Diltiazem HCl. Indications/Uses. Listed in Dosage. Click to view Herbesser 30/Herbesser 60 detailed prescribing information. Dosage/Direction for Use.
About. SANDOZ HONG KONG LIMITED. Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. Our ambition is to be the world's leading and most valued generics company. Mailing Address.
